Business Insider -
26 Aug 2014 23:11

ISIS, or the Islamic State of Iraq and Syria, has gotten lots of attention for the terror it has brought to the Middle East. Unfortunately, this has attracted the wrong kind of attention to companies that coincidentally share the same name as the extremist group. Take ISIS Pharmaceuticals. This $4.3 billion biotech firm surged 10% today, and it's up 43% in the last three months. According to Nasdaq, the stock price crossed above its 200-day moving average for the first time since early spring. I...
Share this Article
Comment on this Article
Please to comment